|
Secondary prevention
Citations 121-130 of 240 total displayed.
|
Past content
(since Jun 2001):
|
- Articles
Reduced Medication Access. A Marker for Vulnerability in US Stroke Survivors
- Deborah A. Levine, Catarina I. Kiefe, George Howard, Virginia J. Howard, O. Dale Williams, and Jeroan J. Allison
Stroke published March 29, 2007, doi:10.1161/STROKEAHA.106.478545
[Abstract]
- Articles
Effects of Peroxisome Proliferator-Activated Receptor Ligands in Modulating Tissue Factor and Tissue Factor Pathway Inhibitor in Acutely Symptomatic Carotid Atheromas
- Jonathan Golledge, Simone Mangan, and Paula Clancy
Stroke published March 15, 2007, doi:10.1161/STROKEAHA.106.474791
[Abstract]
- Original Contributions
Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke: Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)
- Robert Wilcox, Marie-Germaine Bousser, D. John Betteridge, Guntram Schernthaner, Valdis Pirags, Stuart Kupfer, John Dormandy for the PROactive Investigators
Stroke 2007;38:865-873; published online before print as doi:10.1161/01.STR.0000257974.06317.49
[Abstract]
[Full text]
- Original Contributions
Secondary Stroke Prevention With Ximelagatran Versus Warfarin in Patients With Atrial Fibrillation: Pooled Analysis of SPORTIF III and V Clinical Trials
- Paul T. Akins, Harvey A. Feldman, Robert G. Zoble, David Newman, Stefan G. Spitzer, Hans-Christoph Diener, and Gregory W. Albers
Stroke 2007;38:874-880; published online before print as doi:10.1161/01.STR.0000258004.64840.0b
[Abstract]
[Full text]
- Original Contributions
Suboptimal Control of Atherosclerotic Disease Risk Factors After Cardiac and Cerebrovascular Procedures
- Eric M. Cheng, Steve M. Asch, Robert H. Brook, Stefanie D. Vassar, Erin L. Jacob, Martin L. Lee, Donald S. Chang, Ralph L. Sacco, An-Fu Hsiao, and Barbara G. Vickrey
Stroke 2007;38:929-934; published online before print as doi:10.1161/01.STR.0000257310.08310.0f
[Abstract]
[Full text]
- Emerging Therapies
Intensive Statin Therapy After Stroke or Transient Ischemic Attack: A Sparcling Success?
- Bruce Ovbiagele and Jeffrey L. Saver
Stroke 2007;38:1110-1112; published online before print as doi:10.1161/01.STR.0000258216.83927.6a
[Full text]
- Articles
Effects of Pioglitazone in Patients With Type 2 Diabetes With or Without Previous Stroke. Results From PROactive (PROspective pioglitAzone Clinical Trial In macroVascular Events 04)
- Robert Wilcox, Marie-Germaine Bousser, D. John Betteridge, Guntram Schernthaner, Valdis Pirags, Stuart Kupfer, John Dormandy for the PROactive Investigators
Stroke published February 8, 2007, doi:10.1161/01.STR.0000257974.06317.49
[Abstract]
- Articles
Intensive Statin Therapy After Stroke or Transient Ischemic Attack. A Sparcling Success?
- Bruce Ovbiagele and Jeffrey L. Saver
Stroke published February 1, 2007, doi:10.1161/01.STR.0000258216.83927.6a
[Abstract]
- Original Contributions
Reduced Poststroke Mortality in Patients With Stroke and Atrial Fibrillation Treated With Anticoagulants: Results From a Danish Quality-Control Registry of 22 179 Patients With Ischemic Stroke
- Klaus Kaae Andersen and Tom Skyhøj Olsen
Stroke 2007;38:259-263; published online before print as doi:10.1161/01.STR.0000254622.52483.03
[Abstract]
[Full text]
- Try It or Trial It: Introduction
Endarterectomy and Stenting for Asymptomatic Carotid Stenosis: A Race at Breakneck Speed
- Pierre Fayad
Stroke 2007;38:707-714, doi:10.1161/01.STR.0000250047.01624.fd
[Abstract]
[Full text]
|
|
